In this episode I am exploring the rapidly growing rates of obesity globally, the rapid rise in the use of GLP-1s or obesity drugs, how these are impacting our food systems, and how obesity and poverty seem to be linked. In the US around 10% of all Americans are either using GLP-1s or have tried GLP-1s, with early data showing a 5-10% decrease in food spending and a significant change in the foods people are purchasing. Yet, it's only the wealthiest that can afford these drugs.
Today we are joined by Jack Bobo, Director of the Rothman Family institute for food studies at UCLA where he is diving deep into how GLP-1s are reshaping the food system, consumer behavior, and human health.
Obesity rates are skyrocketing globally. In the US 42% of the population is obese and three quarters are overweigh. Australia is hot on the heels of America and much of the world is moving in the same direction. The cost of the is also growing. In the US obesity and metabilic disease are costing about $1 trillion a year and that figure globally it between $10-12 trillion.
Yet it’s complicated, soda consumption and sugar consumption in the US are at 30 year lows, all while obesity is at an all time high. Sugar taxes have let to high income people losing weight and lower income no losing weight. Which follows a general trend that with almost every intervention, healthy people get healthier and unhealthy people don’t.
Jack is also the author of "Why Smart People Make Bad Food Choices"
D'autres épisodes de "ASH CLOUD"
Ne ratez aucun épisode de “ASH CLOUD” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.